全球優質白內障手術 (PCS) 市場（2023 年）：前 13 個國家分析（2023-2029 年）

本報告審視了全球優質白內障手術 (PCS) 市場，提供了市場概況、全球白內障手術和產品收入分析、主要趨勢、未來成功關鍵推動因素的討論，並提供了前 13 個國家的市場趨勢。

目錄

• 老花眼矯正人工水晶體
• 複曲面人工晶狀體
• 中間優化人工水晶體
• 術後可調式人工水晶體
• FLAC雷射
• FLACS弓形切口法
• 手動角膜緣減壓切口
• 準分子人工水晶體增強術
• 前 13 個 PCS 市場（美國、中國、日本、法國、德國、巴西、加拿大、印度、西班牙、韓國、澳洲、英國、義大利）的概述和詳細概況
  • 每個國家的執行摘要
  • 各國白內障手術費用分析
  • 按國家/地區劃分的 PCS 手術和製造商收入預測
  • 按國家/地區劃分的醫療保健提供者 PCS 手術收入和預測
  • 各主要國家中純白內障外科醫生、白內障/屈光外科醫生和僅屈光外科醫生進行的 PCS 手術的百分比
  • 按國家和全球 PCS 市場劃分的製造商收入市場佔有率
  • 按國家列出最重要的 PCS 眼科醫院和診所
  • 接下來六個最重要的 PCS 國家的市場規模排名

What's New:

The new "2024 Premium Cataract Surgery Market Report" now features a five-year history of PC-IOLs, toric IOLs, and FLACS for each of the top 13 premium cataract surgery country markets in the world. For each of these countries, the report also analyzes the recent economy and projects its impact on the elderly populations that account for most premium procedures.

INFOGRAPHICS

The report also explores the long list of recently launched new products that are destined to impact the premium cataract market-including the Carl Zeiss Micor 700 cataract handpiece, which has the potential to drive adoption of office-based cataract surgery; the Rayner Galaxy spiral trifocal IOL and many other new PC-IOLs; and the Lensar Ally, which is expected to drive growth in FLACS procedures.

The new report also examines and explains the dramatic drop in premium procedures in South Korea and outlines the potential recovery of that market over the next five years.

The "2024 Premium Cataract Surgery Market Report" is designed to provide insights into the most important premium cataract surgery (PCS) markets in the world. We've selected and profiled 13 countries that collectively account for 84 percent of global PCS manufacturer revenue and provided a deep dive into each of these markets. Ranked by 2024 PCS manufacturer revenue, they are: the United States, China, Japan, France, Germany, Brazil, Canada, India, Spain, South Korea, Australia, the UK, and Italy.

For each of these countries, the report focuses on specific characteristics considered vital to the understanding of the opportunities for companies planning to market premium cataract surgery devices or looking to assess the value of each market.

Contents:

The report offers an in-depth examination of the 2024 premium cataract surgery (PCS) market. It includes analysis of the global PCS procedure and product revenue, identification of important trends, and discussion of key factors for future success. The following information is also included:

• Presbyopia-correcting, toric, intermediate-optimized, and post-op adjustable IOLs, FLACS lasers, FLACS arcuate incisions, manual limbal relaxing incisions, and excimer IOL enhancements.
• Snapshots and in-depth profiles of the top 13 PCS markets: the United States, China, Japan, France, Germany, Brazil, Canada, India, Spain, South Korea, Australia, the UK, and Italy.
• Individual country executive summary.
• Analysis of the cost of public and private cataract surgery options by country.
• Forecasts for PCS procedures and manufacturer revenue by country.
• Forecasts for provider revenue resulting from PCS procedures by country.
• Percentage of PCS procedures performed in each key country by cataract-only, cataract/refractive, and refractive-only surgeons.
• Manufacturer revenue market shares of the PCS market in each country and globally.
• Listing of the most important PCS eye hospitals and clinics by country.
• A list of the next six most important PCS countries ranked by market size.